BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8958934)

  • 1. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis.
    Germann T; Hess H; Szeliga J; Rüde E
    Ann N Y Acad Sci; 1996 Oct; 795():227-40. PubMed ID: 8958934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
    Szeliga J; Hess H; Rüde E; Schmitt E; Germann T
    Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice.
    Germann T; Szeliga J; Hess H; Störkel S; Podlaski FJ; Gately MK; Schmitt E; Rüde E
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4823-7. PubMed ID: 7761407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Schols D; De Wolf-Peeters C; Billiau A
    J Immunol; 1999 Sep; 163(6):3503-10. PubMed ID: 10477624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo.
    Germann T; Bongartz M; Dlugonska H; Hess H; Schmitt E; Kolbe L; Kölsch E; Podlaski FJ; Gately MK; Rüde E
    Eur J Immunol; 1995 Mar; 25(3):823-9. PubMed ID: 7705414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Billiau A
    Eur J Immunol; 1998 Jul; 28(7):2143-51. PubMed ID: 9692883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II collagen-induced murine arthritis. II. Genetic control of arthritis induction is expressed on L3T4+ T cells required for humoral as well as cell-mediated immune responses to type II collagen.
    Seki N; Sudo Y; Yamane A; Sugihara S; Takai Y; Ishihara K; Ono S; Hamaoka T; Senoh H; Fujiwara H
    Reg Immunol; 1989; 2(4):203-12. PubMed ID: 2577123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
    Stasiuk LM; Abehsira-Amar O; Fournier C
    Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant composition determines the induction of type II collagen-induced arthritis.
    Ellis JS; Chain BM; Cooke A; Ibrahim MA; Katz DR
    Scand J Immunol; 1992 Jul; 36(1):49-56. PubMed ID: 1615283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes, but not streptococcal cell walls or zymosan, cause chronic arthritis in mouse strains susceptible for collagen type II auto-immune arthritis.
    Blom AB; van Lent PL; Holthuysen AE; van den Berg WB
    Cytokine; 1999 Dec; 11(12):1046-56. PubMed ID: 10623430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
    Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
    Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice.
    Yoshino S; Sasatomi E; Ohsawa M
    Immunology; 2000 Apr; 99(4):607-14. PubMed ID: 10792509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
    Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
    Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
    Vermeire K; Thielemans L; Matthys P; Billiau A
    J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses.
    Justa S; Zhou X; Sarkar S
    PLoS One; 2014; 9(3):e93279. PubMed ID: 24676270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of murine collagen-induced arthritis by nasal administration of collagen.
    Myers LK; Seyer JM; Stuart JM; Kang AH
    Immunology; 1997 Feb; 90(2):161-4. PubMed ID: 9135541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis.
    Mauri C; Williams RO; Walmsley M; Feldmann M
    Eur J Immunol; 1996 Jul; 26(7):1511-8. PubMed ID: 8766554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis.
    Butler DM; Malfait AM; Maini RN; Brennan FM; Feldmann M
    Eur J Immunol; 1999 Jul; 29(7):2205-12. PubMed ID: 10427983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.
    Seki N; Sudo Y; Yoshioka T; Sugihara S; Fujitsu T; Sakuma S; Ogawa T; Hamaoka T; Senoh H; Fujiwara H
    J Immunol; 1988 Mar; 140(5):1477-84. PubMed ID: 3257978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.